12:00 AM
Aug 13, 2012
 |  BC Week In Review  |  Company News  |  Deals

Actinium, Philogen deal

Actinium partnered with Philogen to evaluate using Actinium's actinium-225 as the payload in a cancer antibody-drug conjugate with...

Read the full 69 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >